Bhushan Dharmadhikari

Bhushan Dharmadhikari, PhD is currently working at Hummingbird Bioscience as the Director of Target Biology and Pharmacology, leading the development of next-generation antibody-drug conjugates to address limitations of existing therapies. Previously, Bhushan held roles at Engine Biosciences and National University of Singapore where Bhushan focused on drug target discovery, preclinical pharmacology, and clinical trial management. With a background in Biotechnology and a Ph.D. in Immunology & Medicine, Bhushan has a strong foundation in research and development within the field of oncology and immunotherapy.